🇺🇸 FDA
Patent

US 7514436

Pyridazine derivatives and their use as therapeutic agents

granted A61KA61K31/00A61K31/501

Quick answer

US patent 7514436 (Pyridazine derivatives and their use as therapeutic agents) held by Xenon Pharmaceuticals Inc. expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue Apr 07 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/00, A61K31/501, A61K31/551, A61P